Patents by Inventor Gary F. Temple

Gary F. Temple has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040265863
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites and/or multiple topoisomerase recognition sites. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different.
    Type: Application
    Filed: March 4, 2004
    Publication date: December 30, 2004
    Applicant: Invitrogen Corporation
    Inventors: Jonathan D. Chesnut, John Carrino, Louis Leong, Knut Madden, Martin A.G. Gleeson, James Fan, Michael A. Brasch, David Cheo, James L. Hartley, Devon R.N. Byrd, Gary F. Temple
  • Publication number: 20040253631
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: July 19, 2004
    Publication date: December 16, 2004
    Applicant: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20040229229
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites with unique specificity. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different. Such molecules and/or compounds or combinations of such molecules and/or compounds can also be bound through recombination to various structures or supports according to the invention.
    Type: Application
    Filed: August 14, 2003
    Publication date: November 18, 2004
    Applicant: Invitrogen Corporation
    Inventors: David Cheo, Michael A. Brasch, Gary F. Temple, James L. Hartley, Devon R. N. Byrd
  • Publication number: 20040171157
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: April 8, 2004
    Publication date: September 2, 2004
    Applicant: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20040171156
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: April 2, 2004
    Publication date: September 2, 2004
    Applicant: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20040063207
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: October 8, 2003
    Publication date: April 1, 2004
    Applicant: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20040053412
    Abstract: The present invention relates to cells and cell strains that are resistant to the killing effects of one or more toxic genes, particularly those that kill hosts in the absence of a suppressing function, e.g., kicB or ccdB. The host cells may comprise one or more suppression mutations, such as deletional or insertional mutations in gyrA, endA, or recA, or combinations thereof (particularly gyrA/endA or gyrA/recA), which allow cell strains carrying the one or more suppression mutations to survive the presence and/or expression of one or more toxic genes within their genome or in extrachromosomal genetic elements within the host cell. Preferred host cell strains include prokaryotic host cells, particularly specified strains of E. coli containing the gyrA462 mutation and/or one or more additional mutations, such as DB3, DB3.1, DB4 and DB5.
    Type: Application
    Filed: March 26, 2003
    Publication date: March 18, 2004
    Applicant: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple
  • Publication number: 20030186233
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites and/or multiple topoisomerase recognition sites. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different.
    Type: Application
    Filed: December 7, 2001
    Publication date: October 2, 2003
    Applicant: Invitrogen Corporation
    Inventors: Jonathan D. Chesnut, John Carrino, Louis Leong, Knut Madden, Martin Gleeson, James Fan, Michael A. Brasch, David Cheo, James L. Hartley, Devon R.N. Byrd, Gary F. Temple
  • Publication number: 20030175970
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: November 21, 2002
    Publication date: September 18, 2003
    Applicant: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20030157716
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: November 2, 2001
    Publication date: August 21, 2003
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20020192819
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: July 19, 2001
    Publication date: December 19, 2002
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20020172997
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: July 19, 2001
    Publication date: November 21, 2002
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20020094574
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: May 16, 2001
    Publication date: July 18, 2002
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20020007051
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites with unique specificity. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different. Such molecules and/or compounds or combinations of such molecules and/or compounds can also be bound through recombination to various structures or supports according to the invention.
    Type: Application
    Filed: December 11, 2000
    Publication date: January 17, 2002
    Inventors: David Cheo, Michael A. Brasch, Gary F. Temple, James L. Hartley, Devon R. N. Byrd
  • Patent number: 6277608
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: April 22, 1999
    Date of Patent: August 21, 2001
    Assignee: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox